They also found that TUSC2 restoration reduced PD-L1 expression and synergized with anti-PD-1 treatment in KRAS mutant lung cancer models of mice (Meraz et al., 2018; Meraz et al., 2022). This evidence concerns the gene PDCD1 and lung carcinoma.